PET Imaging of Tau Pathology in Alzheimer's Disease and Tauopathies. - Wikidata - awgldk - TriplyDB

PET Imaging of Tau Pathology in Alzheimer's Disease and Tauopathies.

PET Imaging of Tau Pathology in Alzheimer's Disease and Tauopathies.

http://www.wikidata.org/entity/Q35158227

about

Drug Development in Alzheimer's Disease: The Contribution of PET and SPECT PET Imaging of Epigenetic Influences on Alzheimer's Disease Ocular indicators of Alzheimer's: exploring disease in the retina Alzheimer Disease and Its Growing Epidemic: Risk Factors, Biomarkers, and the Urgent Need for Therapeutics.Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease.Meta-Analysis of Transcriptome Data Related to Hippocampus Biopsies and iPSC-Derived Neuronal Cells from Alzheimer's Disease Patients Reveals an Association with FOXA1 and FOXA2 Gene Regulatory Networks.[Molecular imaging in neurological diseases].Antibody-free quantification of seven tau peptides in human CSF using targeted mass spectrometry.Multimodality Review of Amyloid-related Diseases of the Central Nervous System.Aberrant brain stem morphometry associated with sleep disturbance in drug-naïve subjects with Alzheimer's disease Pharmacokinetic Evaluation of the Tau PET Radiotracer 18F-T807 (18F-AV-1451) in Human Subjects.Amyloid-beta immunotherapy: the hope for Alzheimer disease?PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers A Theoretical Analysis of the Synergy of Amyloid and Tau in Alzheimer's Disease.Neurologic Applications of PET/MR Imaging.Emerging ocular biomarkers of Alzheimer disease.Inhomogeneous distribution of Alzheimer pathology along the isocortical relief. Are cortical convolutions an Achilles heel of evolution?Tau imaging with [18 F]THK-5351 in progressive supranuclear palsy.Alzheimer's disease disrupts alpha and beta-band resting-state oscillatory network connectivity.Comparative analysis of the electroencephalogram in patients with Alzheimer's disease, diffuse axonal injury patients and healthy controls using LORETA analysis.Tauopathies: Mechanisms and Therapeutic Strategies.A Quantitative Analysis of Brain Soluble Tau and the Tau Secretion Factor.Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies.Current Perspectives regarding Stem Cell-Based Therapy for Alzheimer's Disease.Potential Utility of Retinal Imaging for Alzheimer’s Disease: A Review.A Closer Look into the Role of Protein Tau in the Identification of Promising Therapeutic Targets for Alzheimer's Disease F-labeled radiopharmaceuticals for the molecular neuroimaging of amyloid plaques in Alzheimer's disease

P2860

Q26749755-B232FFE4-5DB8-4384-8DA9-28CE92260CD1 Q26776178-E4FFD8E8-51CE-4FD8-A0DD-A5B5B1A37CFF Q28078670-DDE6D142-325F-4BF6-97B7-0BBCF022F248 Q30244736-FF420F77-3491-4393-8A8A-5B42BC83F96B Q30276980-60CF70C8-2B57-4358-88C5-41CA6EB763F0 Q31047629-0E149F07-2008-4A72-939E-2DDBC4E76FD1 Q31108303-14C4D1DF-CCFA-4214-89F4-D9DE47868EAF Q36012068-A6783344-DFE5-482B-8B22-7FA2609DFF32 Q37157690-70491E6E-54C5-4331-9C7C-C9832C754139 Q37213267-8BC476F4-7CF6-4A86-8AD5-D7B66105AC32 Q37677783-76079562-1625-45DB-961E-A285319A1F17 Q37679265-8A7C1329-1FBE-478E-BAB0-2042A8890D32 Q38628805-BF4FFC3D-260E-4ACE-A1B4-42F4A01954FC Q38814839-70878D51-A168-4BCB-8839-E998ED505511 Q38846608-B79A9B36-AE1D-4A4F-8894-81B96673F643 Q39113804-6550EF56-3F1C-4C71-80F7-28E38361A0F0 Q39165848-A06A197C-33B1-4605-A759-18F25C351027 Q42501180-C45C449E-87EB-4BCA-9D98-E9694F878A32 Q46323013-92F69C00-1694-41DD-A3DB-2BB6D94F6E38 Q47100093-37A8DB6A-6E26-4616-B05E-EA76E26C0A5B Q47253592-F78C75CB-6232-4ED6-A483-52DD94034981 Q47833026-1268C380-FD64-43D4-B0BA-629DD8D3D1BA Q48389127-A2926183-DFF7-4AFA-9657-AA33BB86B049 Q52568314-FF30A96F-BD18-4C03-AB47-0330D3B0B346 Q55480248-727376B6-A982-4CC4-94A1-1A7544E7EB20 Q57927766-602A080B-A990-4688-B7CC-E4B4DEEE017B Q58733228-8A3A1B7F-B1E0-4306-B746-B0843EAF05B2

P2860

PET Imaging of Tau Pathology in Alzheimer's Disease and Tauopathies.

http://www.wikidata.org/entity/Q35158227

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

PET Imaging of Tau Pathology in Alzheimer's Disease and Tauopathies.

@ast

PET Imaging of Tau Pathology in Alzheimer's Disease and Tauopathies.

@en

type

label

PET Imaging of Tau Pathology in Alzheimer's Disease and Tauopathies.

@ast

PET Imaging of Tau Pathology in Alzheimer's Disease and Tauopathies.

@en

prefLabel

PET Imaging of Tau Pathology in Alzheimer's Disease and Tauopathies.

@ast

PET Imaging of Tau Pathology in Alzheimer's Disease and Tauopathies.

@en

P1433

Q35158227-A493BC99-9625-473B-A612-6062B88FA985

P1476

Q35158227-67782AC1-C7B0-4E7D-A360-589A83E1BE7A

P2093

Q35158227-4C76E6DF-83FC-4BFD-A426-C0E01003E2A2

Q35158227-86D2B5E4-764B-40DA-8785-1D60A4B08E11

Q35158227-C5134462-2EB3-4631-B9D0-63CC9CB83273

P2860

Q35158227-0BECDAA6-9658-4AE4-9C21-01D7CD29C8EC

Q35158227-3F08EDDE-62AF-4218-9BDD-69AE1CD12EEE

Q35158227-407B7E5A-6142-41F0-B88A-B11FF4DDB726

Q35158227-4DFAF1C2-3130-4450-8A99-CAF2CD7C8F0F

Q35158227-580F0552-A50A-4003-BF18-F68F02992BFE

Q35158227-68ED6508-3DDA-424E-ADD5-286E5E621D52

Q35158227-70E754B6-E5B1-4F3A-97DA-6B8251AF8A46

Q35158227-86621659-6093-43C9-B81D-BDD113A40A43

Q35158227-8FB82D8D-C00A-4DFE-9411-2E57983636E4

Q35158227-93A87235-40DA-4341-8994-7391A31D9762

P304

Q35158227-FD81A065-306D-45DC-A0FF-9C26FF92423C

P31

Q35158227-2B80F1AE-0E5E-4F3D-8196-48503A07C5AD

P356

Q35158227-24755377-3722-4464-AC72-A53A439D0F79

P478

Q35158227-4EAB8598-22FD-4416-8ED2-7EF168ECBACB

P577

Q35158227-F8354468-4624-4623-9128-21DCFF6AA316

P5875

Q35158227-62AF25E5-5D38-453A-BECE-0E2CBA643FF4

P698

Q35158227-EC795C03-F48A-4836-A0F8-63852CD91C02

P921

Q35158227-C6F54974-1C3C-44F6-AFDF-BB8787409A88

P932

Q35158227-0D61A684-1F93-40A0-839C-FB756204FAAE

P356

FNEUR.2015.00038

P1433

Frontiers in Neurology

P1476

PET Imaging of Tau Pathology in Alzheimer's Disease and Tauopathies.

@en

P2093

Olga G James

http://www.w3.org/2001/XMLSchema#string

P Murali Doraiswamy

http://www.w3.org/2001/XMLSchema#string

Salvador Borges-Neto

http://www.w3.org/2001/XMLSchema#string

P2860

Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.

Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study.

Tau in Alzheimer disease and related tauopathies.

The global prevalence of dementia: a systematic review and metaanalysis.

Challenges of multimorbidity of the aging brain: a critical update.

In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease.

Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807.

Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline.

P304

38

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FNEUR.2015.00038

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274089737

http://www.w3.org/2001/XMLSchema#string

P698

25806018

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4353301

http://www.w3.org/2001/XMLSchema#string